Ledger.Open graph →
SEC Form D · Amendment · filed December 17, 2021

Attivare Therapeutics, Inc

Offering
$7.8M
Sold
$5.9M
Exemption
Rule 506(b)
Industry
Other
Location
NATICK, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Zeshan Muhammedi · Natick, MADirectorEdward Doherty · Natick, MAExecJoaquim Trias · Natick, MAExec · DirectorJessica Mcdonough · Natick, MADirectorJonathan F. Frangakis · Raleigh, NCDirectorCasey Swercheck · Delray Beach, FLExecRobert Konrad · Delray Beach, FLDirectorRobert Konrad · Delray Beach, FLExec · DirectorJeffrey W. Koonce · Baton Rouge, LADirectorLuther C. Kissam Iv · Baton Rouge, LADirectorMark W. Spender · Baton Rouge, LAExecKathleen M. Courtis · CHICAGO, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗